{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:45:50Z","timestamp":1787600750292,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Untreated pathological cardiac hypertrophy, which can be caused by sustained systemic hypertension, may lead to heart failure. In the present study, we investigated whether AS-1 had attenuating effects on hypertension-induced cardiac hypertrophy, and whether this process was mediated by the regulation of miRNA-143. To induce the hypertrophic response <jats:italic>in vitro<\/jats:italic>, cardiomyocytes were stimulated with Ang II for 24hs. AS-1 administration strongly attenuated Ang II-induced hypertrophic response of cardiomyocytes. Chronical infusion of Ang II via implanted osmotic mini-pump induced increased blood pressure and cardiac hypertrophy <jats:italic>in vivo<\/jats:italic>. AS-1 administration attenuated hypertension-induced cardiac hypertrophy by, at least in part, inhibin of MAPK signaling. We observed, for the first time, upregulated expression of miRNA-143 in Ang II-induced cardiomyocytes, and inhibition of miRNA-143 significantly reduced the Ang II-induced hypertrophic responses. Importantly, AS-1 administration diminished the Ang II-induced upregulation of miRNA-143. Overexpression of miRNA-143 abolished the attenuating effects of AS-1 on Ang II-induced hypertrophic response of cardiomyocytes. Additionally, AS-1 administration abrogates Ang II-induced nuclear translocation of p50 NF-\u03baB subunit in hypertrophic cardiomyocytes. Application of NF-\u03baB inhibitor significantly suppressed Ang II-induced upregulation of miRNA-143. Our data suggest a novel mechanism by which AS-1 attenuates Ang II-induced hypertrophic response through downregulation miRNA-143 expression in a NF-\u03baB-dependent manner.<\/jats:p>","DOI":"10.1038\/s41598-019-42936-x","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T10:04:03Z","timestamp":1556013843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The TIR\/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-\u03baB dependent downregulation of miRNA-143"],"prefix":"10.1038","volume":"9","author":[{"given":"Juan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"42936_CR1","doi-asserted-by":"publisher","first-page":"A1011","DOI":"10.1016\/S0735-1097(14)61011-1","volume":"63","author":"YS Hamirani","year":"2014","unstructured":"Hamirani, Y. S., Zhong, M., Mcbride, A., Bourque, J. & Kundu, B. Myocardial Metabolic Remodeling in Hypertension Induced Left Ventricular Hypertrophy. J Am Coll Cardiol 63, A1011\u2013A1011, https:\/\/doi.org\/10.1016\/S0735-1097(14)61011-1 (2014).","journal-title":"J Am Coll Cardiol"},{"key":"42936_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.amjmed.2014.10.054","volume":"128","author":"F Rader","year":"2015","unstructured":"Rader, F., Sachdev, E., Arsanjani, R. & Siegel, R. J. Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications. Am J Med 128, 344\u2013352, https:\/\/doi.org\/10.1016\/j.amjmed.2014.10.054 (2015).","journal-title":"Am J Med"},{"key":"42936_CR3","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1113\/JP271161","volume":"593","author":"AN Kavazis","year":"2015","unstructured":"Kavazis, A. N. Pathological vs. physiological cardiac hypertrophy. J Physiol 593, 3767, https:\/\/doi.org\/10.1113\/JP271161 (2015).","journal-title":"J Physiol"},{"key":"42936_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/Jci62839","volume":"123","author":"JH van Berlo","year":"2013","unstructured":"van Berlo, J. H., Maillet, M. & Molkentin, J. D. Signaling effectors underlying pathologic growth and remodeling of the heart. Journal of Clinical Investigation 123, 37\u201345, https:\/\/doi.org\/10.1172\/Jci62839 (2013).","journal-title":"Journal of Clinical Investigation"},{"key":"42936_CR5","doi-asserted-by":"publisher","first-page":"531740","DOI":"10.1155\/2015\/531740","volume":"2015","author":"W Zhao","year":"2015","unstructured":"Zhao, W., Zhao, S. P. & Zhao, Y. H. MicroRNA-143\/-145 in Cardiovascular Diseases. Biomed Res Int 2015, 531740, https:\/\/doi.org\/10.1155\/2015\/531740 (2015).","journal-title":"Biomed Res Int"},{"key":"42936_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-387786-4.00009-9","volume":"100","author":"RA Espinoza-Lewis","year":"2012","unstructured":"Espinoza-Lewis, R. A. & Wang, D. Z. MicroRNAs in heart development. Curr Top Dev Biol 100, 279\u2013317, https:\/\/doi.org\/10.1016\/B978-0-12-387786-4.00009-9 (2012).","journal-title":"Curr Top Dev Biol"},{"key":"42936_CR7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/sj.bjc.6603023","volume":"94","author":"HW Hwang","year":"2006","unstructured":"Hwang, H. W. & Mendell, J. T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94, 776\u2013780, https:\/\/doi.org\/10.1038\/sj.bjc.6603023 (2006).","journal-title":"Br J Cancer"},{"key":"42936_CR8","doi-asserted-by":"publisher","unstructured":"Yan, S. & Jiao, K. Functions of miRNAs during Mammalian Heart Development. Int J Mol Sci 17, https:\/\/doi.org\/10.3390\/ijms17050789 (2016).","DOI":"10.3390\/ijms17050789"},{"key":"42936_CR9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","volume":"114","author":"HY Seok","year":"2014","unstructured":"Seok, H. Y. et al. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy. Circ Res 114, 1585\u20131595, https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.303784 (2014).","journal-title":"Circ Res"},{"key":"42936_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCRESAHA.108.192872","volume":"104","author":"KR Cordes","year":"2009","unstructured":"Cordes, K. R. & Srivastava, D. MicroRNA regulation of cardiovascular development. Circ Res 104, 724\u2013732, https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.192872 (2009).","journal-title":"Circ Res"},{"key":"42936_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1161\/CIRCULATIONAHA.116.024171","volume":"136","author":"WA Heggermont","year":"2017","unstructured":"Heggermont, W. A. et al. Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction. Circulation 136, 747\u2013761, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024171 (2017).","journal-title":"Circulation"},{"key":"42936_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13, 613\u2013618, https:\/\/doi.org\/10.1038\/nm1582 (2007).","journal-title":"Nat Med"},{"key":"42936_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/hrt.2004.042473","volume":"91","author":"T Kahan","year":"2005","unstructured":"Kahan, T. & Bergfeldt, L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart 91, 250\u2013256, https:\/\/doi.org\/10.1136\/hrt.2004.042473 (2005).","journal-title":"Heart"},{"key":"42936_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/039463201202500216","volume":"25","author":"GD Norata","year":"2012","unstructured":"Norata, G. D. et al. MicroRNA 143-145 deficiency impairs vascular function. Int J Immunopathol Pharmacol 25, 467\u2013474, https:\/\/doi.org\/10.1177\/039463201202500216 (2012).","journal-title":"Int J Immunopathol Pharmacol"},{"key":"42936_CR15","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1172\/JCI38864","volume":"119","author":"T Boettger","year":"2009","unstructured":"Boettger, T. et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster. J Clin Invest 119, 2634\u20132647, https:\/\/doi.org\/10.1172\/JCI38864 (2009).","journal-title":"J Clin Invest"},{"key":"42936_CR16","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/RES.0000000000000136","volume":"120","author":"Correction to: miR-143","year":"2017","unstructured":"Correction to: miR-143. Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Circ Res 120, e6, https:\/\/doi.org\/10.1161\/RES.0000000000000136 (2017).","journal-title":"Circ Res"},{"key":"42936_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.bbadis.2016.03.002","volume":"1862","author":"M Fan","year":"2016","unstructured":"Fan, M. et al. The TIR\/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1. Biochim Biophys Acta 1862, 1191\u20131202, https:\/\/doi.org\/10.1016\/j.bbadis.2016.03.002 (2016).","journal-title":"Biochim Biophys Acta"},{"key":"42936_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00395-011-0182-z","volume":"106","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y. et al. The TIR\/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling. Basic Res Cardiol 106, 787\u2013799, https:\/\/doi.org\/10.1007\/s00395-011-0182-z (2011).","journal-title":"Basic Res Cardiol"},{"key":"42936_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep44638","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu, Y. et al. TIR\/BB-loop mimetic AS-1 attenuates cardiac ischemia\/reperfusion injury via a caveolae and caveolin-3-dependent mechanism. Sci Rep 7, 44638, https:\/\/doi.org\/10.1038\/srep44638 (2017).","journal-title":"Sci Rep"},{"key":"42936_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","volume":"73","author":"J Sadoshima","year":"1993","unstructured":"Sadoshima, J. & Izumo, S. Molecular characterization of angiotensin II\u2013induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73, 413\u2013423 (1993).","journal-title":"Circ Res"},{"key":"42936_CR21","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/JME-16-0086","volume":"57","author":"L Zhou","year":"2016","unstructured":"Zhou, L., Ma, B. & Han, X. The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy. J Mol Endocrinol 57, R143\u2013R152, https:\/\/doi.org\/10.1530\/JME-16-0086 (2016).","journal-title":"J Mol Endocrinol"},{"key":"42936_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/emm.2007.8","volume":"39","author":"L Yang","year":"2007","unstructured":"Yang, L. et al. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK\/ERK pathway. Exp Mol Med 39, 65\u201373, https:\/\/doi.org\/10.1038\/emm.2007.8 (2007).","journal-title":"Exp Mol Med"},{"key":"42936_CR23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1242\/dev.050526","volume":"137","author":"DC Deacon","year":"2010","unstructured":"Deacon, D. C. et al. The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 137, 1887\u20131896, https:\/\/doi.org\/10.1242\/dev.050526 (2010).","journal-title":"Development"},{"key":"42936_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0195-668X(02)00829-1","volume":"24","author":"DJ Lips","year":"2003","unstructured":"Lips, D. J., deWindt, L. J., van Kraaij, D. J. & Doevendans, P. A. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur Heart J 24, 883\u2013896 (2003).","journal-title":"Eur Heart J"},{"key":"42936_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcad.2006.02.001","volume":"48","author":"AH Gradman","year":"2006","unstructured":"Gradman, A. H. & Alfayoumi, F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48, 326\u2013341, https:\/\/doi.org\/10.1016\/j.pcad.2006.02.001 (2006).","journal-title":"Prog Cardiovasc Dis"},{"key":"42936_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli, F. H., Rimoldi, S. F. & Bangalore, S. The Transition From Hypertension to Heart Failure: Contemporary Update. JACC Heart Fail 5, 543\u2013551, https:\/\/doi.org\/10.1016\/j.jchf.2017.04.012 (2017).","journal-title":"JACC Heart Fail"},{"key":"42936_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1023\/A:1024119224033","volume":"247","author":"T Ravingerova","year":"2003","unstructured":"Ravingerova, T., Barancik, M. & Strniskova, M. Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol Cell Biochem 247, 127\u2013138 (2003).","journal-title":"Mol Cell Biochem"},{"key":"42936_CR28","doi-asserted-by":"publisher","first-page":"24R","DOI":"10.1203\/pdr.0b013e3180457684","volume":"61","author":"JC Chuang","year":"2007","unstructured":"Chuang, J. C. & Jones, P. A. Epigenetics and microRNAs. Pediatr Res 61, 24R\u201329R, https:\/\/doi.org\/10.1203\/pdr.0b013e3180457684 (2007).","journal-title":"Pediatr Res"},{"key":"42936_CR29","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/cdd.2009.153","volume":"16","author":"L Elia","year":"2009","unstructured":"Elia, L. et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16, 1590\u20131598, https:\/\/doi.org\/10.1038\/cdd.2009.153 (2009).","journal-title":"Cell Death Differ"},{"key":"42936_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/hc0302.103712","volume":"105","author":"JK Bendall","year":"2002","unstructured":"Bendall, J. K., Cave, A. C., Heymes, C., Gall, N. & Shah, A. M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105, 293\u2013296 (2002).","journal-title":"Circulation"},{"key":"42936_CR31","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.105.538934","volume":"112","author":"A Dikalova","year":"2005","unstructured":"Dikalova, A. et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112, 2668\u20132676, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.538934 (2005).","journal-title":"Circulation"},{"key":"42936_CR32","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/CIRCULATIONAHA.108.813576","volume":"119","author":"SJ Matkovich","year":"2009","unstructured":"Matkovich, S. J. et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119, 1263\u20131271, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.813576 (2009).","journal-title":"Circulation"},{"key":"42936_CR33","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1073\/pnas.0932746100","volume":"100","author":"T Bartfai","year":"2003","unstructured":"Bartfai, T. et al. A low molecular weight mimic of the Toll\/IL-1 receptor\/resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci USA 100, 7971\u20137976, https:\/\/doi.org\/10.1073\/pnas.0932746100 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"42936_CR34","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/bph.13786","volume":"174","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. The TIR\/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation. Br J Pharmacol 174, 1841\u20131856, https:\/\/doi.org\/10.1111\/bph.13786 (2017).","journal-title":"Br J Pharmacol"},{"key":"42936_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0014-5793(03)00747-6","volume":"548","author":"S Janssens","year":"2003","unstructured":"Janssens, S., Burns, K., Vercammen, E., Tschopp, J. & Beyaert, R. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression. FEBS Lett 548, 103\u2013107 (2003).","journal-title":"FEBS Lett"},{"key":"42936_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.yjmcc.2014.11.006","volume":"79","author":"J Song","year":"2015","unstructured":"Song, J. et al. Pellino1-mediated TGF-beta1 synthesis contributes to mechanical stress induced cardiac fibroblast activation. J Mol Cell Cardiol 79, 145\u2013156, https:\/\/doi.org\/10.1016\/j.yjmcc.2014.11.006 (2015).","journal-title":"J Mol Cell Cardiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42936-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42936-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42936-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:51:34Z","timestamp":1671267094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42936-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42936"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42936-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"28 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6354"}}